Comment on - Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis

被引：0
|
作者：
Pandita, Amit [1 ]
Shabil, Muhammed [2 ,3 ]
Sah, Sanjit [4 ,5 ]
机构：
[1] Graph Era, Dept Gastroenterol, Era Inst Med Sci G, Med Coll& Hosp, Clement Town, Dehra Dun 248002, India
[2] Saveetha Univ, Ctr Global Hlth Res, Saveetha Inst Med & Tech Sci, Saveetha Med Coll& Hosp, Chennai 600077, India
[3] AL Mustaqbal Univ, Med Labs Tech Dept, Babil 51001, Hillah, Iraq
[4] Dr D Y Patil Med Coll Hosp & Res Ctr, Dept Paediat, Pune 411018, India
[5] D D Y Patil Vidyapeeth, D D Y Patil Dent Coll & Hosp, Dept Publ Hlth Dent, Pune 411018, India
来源：
INDIAN JOURNAL OF GASTROENTEROLOGY | 2024年
关键词：
D O I：
10.1007/s12664-024-01702-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：270 / 271
页数：2
相关论文
共 50 条
  • [21] Antituberculosis Drug-induced Liver Injury in Children Incidence and Risk Factors During the Two-month Intensive Phase of Therapy
    Gafar, Fajri
    Arifin, Helmi
    Jurnalis, Yusri D.
    Yani, Finny F.
    Fitria, Najmiatul
    Alffenaar, Jan-Willem C.
    Wilffert, Bob
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (01) : 50 - 53
  • [22] Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug Regimens
    Nicoletti, Paola
    Devarbhavi, Harshad
    Goel, Ashish
    Venkatesan, Radha
    Eapen, Chundamannil E.
    Grove, Jane, I
    Zafer, Samreen
    Bjornsson, Einar
    Lucena, M. Isabel
    Andrade, Raul J.
    Pirmohamed, Munir
    Wadelius, Mia
    Larrey, Dominique
    Maitland-van der Zee, Anke-Hilse
    Ibanez, Luisa
    Watkins, Paul B.
    Daly, Ann K.
    Aithal, Guruprasad P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (04) : 1125 - 1135
  • [23] Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials
    Tao, Lina
    Qu, Xiaoyu
    Zhang, Yue
    Song, Yanqing
    Zhang, Si-xi
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 2019
  • [24] Adaptation and Antituberculosis Drug-induced Liver Injury Reply
    Singanayagam, Aran
    Burroughs, Andrew K.
    Kon, Onn Min
    Wickremasinghe, Melissa
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (04) : 388 - 389
  • [25] Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury
    Huang, Yi-Shin
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (04) : 169 - 173
  • [26] Drug-induced liver injury by glecaprevir/pibrentasvir treatment for chronic hepatitis C infection: a systematic review and meta-analysis
    Hung, Hsuan-Yu
    Hung, Wei-Liang
    Shih, Chia-Lung
    Chen, Chung-Yu
    ANNALS OF MEDICINE, 2022, 54 (01) : 108 - 120
  • [27] Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases
    Tan, Eng Hooi
    Low, En Xian Sarah
    Dan, Yock Young
    Tai, Bee Choo
    LIVER INTERNATIONAL, 2018, 38 (04) : 742 - 753
  • [28] Relevance of NAT2 genotype and clinical factors to risk for antituberculosis drug-induced liver injury
    Cheng, Fang
    Qiu, Chao-Chao
    Jiang, Xian-Gao
    Wu, Te
    Zhang, Qiang
    Chen, Xin
    Zheng, Shi-Lin
    Liu, Sai-Duo
    Ye, Xin-Chun
    Shi, Ji-Chan
    PHARMACOGENOMICS, 2024, 25 (01) : 21 - 28
  • [29] Risk of Drug-Induced Liver Injury in Patients With Chronic Hepatitis B and Active Tuberculosis Co-Infection: A Systematic Review and Meta-Analysis
    Chou, Christina
    Veracruz, Nicolette
    Chitnis, Amit S.
    Wong, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S554 - S555
  • [30] Risk Factors for Idiosyncratic Drug-Induced Liver Injury
    Chalasani, Naga
    Bjornsson, Einar
    GASTROENTEROLOGY, 2010, 138 (07) : 2246 - 2259
12345